Insmed Incorporated
INSM
$123.74
-$2.59-2.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 185.76% | 115.09% | 66.73% | 30.34% | 21.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 185.76% | 115.09% | 66.73% | 30.34% | 21.15% |
| Cost of Revenue | 94.69% | 66.45% | 43.38% | 34.39% | 31.40% |
| Gross Profit | 214.97% | 130.04% | 73.94% | 29.15% | 18.19% |
| SG&A Expenses | 58.51% | 55.34% | 52.06% | 54.66% | 48.42% |
| Depreciation & Amortization | 51.17% | 34.98% | 18.78% | 5.44% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.10% | 43.93% | 39.20% | 37.29% | 36.33% |
| Operating Income | 12.40% | -12.36% | -26.47% | -40.68% | -44.08% |
| Income Before Tax | 15.61% | -16.74% | -39.74% | -36.97% | -28.78% |
| Income Tax Expenses | 39.91% | 38.44% | 35.58% | 37.86% | 49.38% |
| Earnings from Continuing Operations | 15.38% | -16.83% | -39.73% | -36.97% | -28.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.38% | -16.83% | -39.73% | -36.97% | -28.86% |
| EBIT | 12.40% | -12.36% | -26.47% | -40.68% | -44.08% |
| EBITDA | 13.35% | -11.67% | -26.07% | -40.82% | -44.49% |
| EPS Basic | 28.02% | 3.42% | -14.62% | -11.26% | -5.65% |
| Normalized Basic EPS | 25.33% | 6.79% | -3.43% | -12.24% | -14.02% |
| EPS Diluted | 27.99% | 3.38% | -14.66% | -11.30% | -5.66% |
| Normalized Diluted EPS | 25.33% | 6.79% | -3.43% | -12.24% | -14.02% |
| Average Basic Shares Outstanding | 18.72% | 20.61% | 21.29% | 22.40% | 22.35% |
| Average Diluted Shares Outstanding | 18.72% | 20.61% | 21.29% | 22.40% | 22.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |